A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis

EMBO Reports

Volumn 12, Issue 7, 2011, Pages 682-689

  Taniue, Kenzui ^a   Oda, Takeaki ^a   Hayashi, Tomoatsu ^a   Okuno, Masumi ^a   Akiyama, Tetsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

ETS; histone modification; p53; RUVBL1

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HISTONE H2B; PROTEIN P53; RUVBL 1 ENZYME; TRANSCRIPTION FACTOR EHF; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; COLON TUMOR; GENE TARGETING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL; UBIQUITINATION; UPREGULATION;

APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HISTONES; HUMANS; METHYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; UP-REGULATION;

EID: 79960002978     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2011.81     Document Type: Article

References (24)

1. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501 (Pubitemid 28538613)
2. Cobleigh MA et al (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17: 2639-2648 (Pubitemid 29415219)
3. Ding L et al (2009) A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4: 403-415
4. Felsher DW (2008) Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Cancer Res 68: 3081-3086
5. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15: 3249-3262 (Pubitemid 34008191)
6. Gallant P (2007) Control of transcription by Pontin and Reptin. Trends Cell Biol 17: 187-192 (Pubitemid 46507808)
7. Herbst RS, Fukuoka M, Baselga J (2004) Gefitinib-a novel targeted approach to treating cancer. Nat Rev Cancer 4: 956-965 (Pubitemid 39626219)
8. Huber O, Menard L, Haurie V, Nicou A, Taras D, Rosenbaum J (2008) Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res 68: 6873-6876
9. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248 (Pubitemid 34008190)
10. Jha S, Dutta A (2009) RVB1/RVB2: running rings around molecular biology. Mol Cell 34: 521-533
11. Kawasaki Y, Tsuji S, Muroya K, Furukawa S, Shibata Y, Okuno M, Ohwada S, Akiyama T (2009) The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+) mice. EMBO Rep 10: 1355-1362
12. Kleinbaum LA, Duggan C, Ferreira E, Coffey GP, Buttice G, Burton FH (1999) Human chromosomal localization, tissue/tumor expression, and regulatory function of the ets family gene EHF. Biochem Biophys Res Commun 264: 119-126 (Pubitemid 29500474)
13. Meek DW (2009) Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723
14. Minsky N, Shema E, Field Y, Schuster M, Segal E, Oren M (2008) Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol 10: 483-488
15. Pavri R, Zhu B, Li G, Trojer P, Mandal S, Shilatifard A, Reinberg D (2006) Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125: 703-717 (Pubitemid 43732350)
16. Seth A, Watson DK (2005) ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41: 2462-2478 (Pubitemid 41540623)
17. Shaffer AL et al (2008) IRF4 addiction in multiple myeloma. Nature 454: 226-231 (Pubitemid 351969894)
18. Sharrocks AD (2001) The ETS-domain transcription factor family. Nat Rev Mol Cell 2: 827-837 (Pubitemid 33674083)
19. Shema E et al (2008) The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev 22: 2664-2676
20. Wasylyk B, Hagman J, Gutierrez-Hartmann A (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23: 213-216 (Pubitemid 28302618)
21. Weinstein IB, Joe A (2008) Oncogene addiction. Cancer Res 68: 3077-3080
22. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660 (Pubitemid 46232886)
23. Yang YJ, Han JW, Youn HD, Cho EJ (2010) The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res 38: 382-390
24. Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25: 5052-5060 (Pubitemid 40781105)